Figure 3.
Proposed algorithm for evaluation and treatment of liver disease in association with onasemnogene. A, Pregene therapy evaluation for existing chronic liver disease or predisposition to liver disease. B, Post gene therapy monitoring for liver damage and treatment recommendations if liver damage occurs. Ab, antibody; PT, prothrombin time.